Immunization Action Coalition receives $1.4 million award from CDC

October 25, 2011

St. Paul, Minnesota, -- The Immunization Action Coalition (IAC), one of the nation's premier sources of immunization information, and the National Center for Immunization and Respiratory Diseases (NCIRD) of the Centers for Disease Control and Prevention (CDC) are entering into a cooperative agreement that will distribute IAC's highly regarded publications to pediatricians, family physicians, and other healthcare professionals involved in providing immunization services. The award is for $1.4 million over five years.

This cooperative agreement will support three key current IAC functions: (1) creation and distribution of weekly editions of IAC Express to IAC's email subscribers; (2) publication of the feature "Ask the Experts," in which CDC and IAC immunization experts answer questions from vaccine providers; and (3) creation of new immunization education materials designed to respond to the needs of immunization providers, parents, and patients. Importantly, the new agreement also makes IAC the nation's central clearinghouse for Vaccine Information Statements (VISs) in languages other than English.

VISs are the foundation of patient/parent-centered vaccination delivery. Mandated by the National Childhood Vaccine Injury Act, these information sheets help ensure that families receive essential information about each vaccine including, for example, the vaccine's benefits and potential side effects. Proper distribution of the VISs will inform vaccine recipients, or their parents or legal representatives, about the vaccine prior to receiving a dose. Providing this important information in a wide array of languages upholds IAC's and CDC/NCIRD's shared dedication to giving all Americans access to the vaccination information they need.

"This partnership between CDC and IAC will significantly improve the immunization information available to those patients and parents who are best communicated with in languages other than English," said IAC's Executive Director, Deborah Wexler, MD.
-end-
About the Immunization Action Coalition

IAC's immunization educational tools have a strong impact on the education, attitudes, and practices of healthcare professionals throughout the nation, making IAC one of the most respected and relied-upon immunization organizations in the United States. IAC is also a direct source of immunization information for the public. IAC's two major websites receive more than 20,000 visits per day, and its email news service broadcasts weekly immunization updates to more than 45,000 opt-in subscribers. The new cooperative agreement sustains this keystone of U.S. immunization information.

Dr. Wexler is available for interviews about the impact of this grant.

Immunization Action Coalition

Related Vaccine Articles from Brightsurf:

Who should get the COVID-19 vaccine first?
Nineteen global health experts from around the world have proposed a new, three-phase plan for vaccine distribution -- called the Fair Priority Model -- which aims to reduce premature deaths and other irreversible health consequences from COVID-19.

Breakthrough with cancer vaccine
Scientists have developed a new cancer vaccine with the potential to activate the body's immune system to fight a range of cancers, including leukaemia, breast cancer, lung cancer and pancreatic cancers.

How to improve the pneumococcus vaccine
Pneumococcus kills 1 million children annually according to the World Health Organization.

US inroads to better Ebola vaccine
As the world focuses on finding a COVID-19 vaccine, research continues on other potentially catastrophic pandemic diseases, including Ebola and Marburg viruses.

Successful MERS vaccine in mice may hold promise for COVID-19 vaccine
In a new study, published April 7 in mBio, researchers from the University of Iowa and the University of Georgia demonstrate that a new vaccine fully protects mice against a lethal dose of MERS, a close cousin of COVID-19.

Coronavirus Vaccine: Where are we and what's next? (video)
You might have heard that COVID-19 vaccine trials are underway in Seattle.

Why isn't there a vaccine for staph?
A study from Washington University School of Medicine in St.

Exposing vaccine hesitant to real-life pain of diseases makes them more pro-vaccine
New research from Brigham Young University professors finds there is a better way to help increase support for vaccinations: Expose people to the pain and suffering caused by vaccine-preventable diseases instead of trying to combat people with vaccine facts.

Lifetime flu vaccine?
Another year, another flu vaccine because so far scientists haven't managed to make a vaccine that protects against all strains of flu.

On the horizon: An acne vaccine
A new study published in the Journal of Investigative Dermatology reports important steps that have been taken towards the development of an acne vaccine.

Read More: Vaccine News and Vaccine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.